Second Irish company proposes say-on-pay vote

8 January 2010

Sarah Wilson

EU regulation

United Drug has followed the lead of DCC in proposing a vote on its remuneration report as a separate voting item at its upcoming AGM on 9 February. The notice of meeting acknowledges that there is no legal obligation on the company to put such a resolution to shareholders, so this is an ‘advisory’ resolution and is not binding on the company. The company confirmed to Manifest that it viewed the proposing of such a resolution as emerging best practice for Irish companies.

The development follows Manifest's campaign in 2009 seeking the addition of say-on-pay votes at the AGMs of five Irish companies. It is hoped that further Irish companies will introduce such a resolution in 2010 - indeed some of the companies targeted in Manifest's 2009 campaign undertook to review this ahead of their 2010 AGMs.

Neither the Irish Companies Acts nor the Listing Rules of the Irish Stock Exchange require companies to propose their Remuneration Report for shareholder approval. The Irish Stock Exchange previously adopted the UK’S 1998 Combined Code which recommended that directors should consider whether such a resolution should be proposed.

Latest News

SHareholder meeting

SEC 2027 examination priorities put fresh focus on proxy advisor oversight

SHareholder meeting

Saba’s Baillie Gifford board challenge falls short, but pressure on trusts likely to persist

SHareholder meeting

ICCR urges investors to encourage company support against Rule 14a-8 rescission proposal

SHareholder meeting

Fifteen financial institutions push ISSB towards dedicated Nature Standard

SHareholder meeting

NA100 benchmark shows nature commitments progress as investors strengthen engagement efforts

SHareholder meeting

ESMA's Transition and Impact Claims Guidance: Lessons for SFDR II

Featured Briefings

Minerva Briefing

2026 United States of America Proxy Season Review

Minerva Briefing

US SEC Rule 14a-8 Rescission Proposal

Minerva Briefing

2026 Global Proxy Season Review

Minerva is a global provider of sustainable stewardship solutions with over 30 years of expertise. Minerva empowers investors by providing essential tools, including ESG research and data and expert insights, enabling them to navigate the intricate and ever-evolving landscape of stewardship and proxy voting, whilst ensuring their decisions are well-informed and aligned with sustainable principles.

Related Stories

 Baillie Gifford

Saba’s Baillie Gifford board challenge falls short, but pressure on trusts likely to persist

October 30, 2026
Read More
Procter & Gamble shareholder rights proposals

Procter & Gamble shareholder rights proposals draw significant support

October 22, 2026
Read More

Minerva Proxy Update

June 12, 2026
Read More
shareholder meetings and proxy voting

Minerva Proxy Update

June 5, 2026
Read More
Exon logo

ExxonMobil’s Texas redomicile passes with high dissent

June 5, 2026
Read More
AGM, Proxy Season, Shareholder Proposals

Minerva Proxy Update

May 29, 2026
Read More